GI
ASND icon

GAMMA Investing’s Ascendis Pharma A/S ASND Stock Holding History

GAMMA Investing’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$360K Buy
1,581
+544
+52% +$138K 0.01% 904
2026
Q2 		$277K Buy
1,037
+80
+8% +$18.7K 0.01% 1030
2026
Q1 		$219K Buy
957
+107
+13% +$24K 0.01% 1048
2025
Q4 		$181K Buy
850
+115
+16% +$23.8K 0.01% 1111
2025
Q3 		$146K Buy
735
+97
+15% +$18.1K 0.01% 1198
2025
Q2 		$110K Buy
638
+51
+9% +$8.31K 0.01% 1367
2025
Q1 		$91.5K Buy
587
+4
+0.7% +$571 0.01% 1334
2024
Q4 		$80.3K Buy
583
+214
+58% +$28.1K 0.01% 1280
2024
Q3 		$55.1K Buy
369
+64
+21% +$8.64K 0.01% 1421
2024
Q2 		$41.6K Buy
305
+7
+2% +$952 0.01% 1323
2024
Q1 		$45K Buy
298
+102
+52% +$14.6K 0.01% 1112
2023
Q4 		$25.5K Buy
+196
New +$19.5K 0.01% 1333

Other funds holding ASND

SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
BONH
Bank of New Hampshire Laconia, New Hampshire $463M AUM 23.57% 1-Year Est. Return
RF
Roxbury Financial Mount Arlington, New Jersey $130M AUM 20.04% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
AAG
Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return

GAMMA Investing's ASND Position: Q3 2026 in Review

GAMMA Investing increased its Ascendis Pharma A/S (ASND) stake by 52% in Q3 2026, buying an estimated $138K and bringing the position to 1,581 shares worth $360K. The position accounts for 0.01% of the portfolio, ranked #904.

GAMMA Investing first reported a position in ASND in Q4 2023 and has held it in 12 quarters since. 10 funds tracked by Wall St. Rank hold ASND as of Q3 2026.

  • GAMMA Investing held 1,581 shares of Ascendis Pharma A/S worth $360K as of Q3 2026.
  • GAMMA Investing bought 544 Ascendis Pharma A/S shares in Q3 2026, an estimated $138K.
  • Ascendis Pharma A/S made up 0.01% of GAMMA Investing's portfolio in Q3 2026, its #904 holding.
  • GAMMA Investing first reported a position in Ascendis Pharma A/S in Q4 2023 and has held it in 12 quarters since.
  • 10 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.